The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras
Open Access
- 14 March 2014
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 89 (6) , 633-638
Abstract
The impact of race/ethnicity and the additional factors of age, sex, and socioeconomic status (SES) on follicular lymphoma (FL) outcomes have not been comprehensively studied and are not well defined. We examined population‐based FL data from >18,000 patients in SEER‐13 (1992–2009) investigating race/ethnicity and the impact of relevant factors including sex, age, and SES. Further, we compared data over two consecutive periods: Era‐1 (1992–2000, n = 8,355) and Era‐2 (2001–2009, n = 10,475). We identified 18,830 FL patients (White: n = 15,116; Hispanic: n = 1,627; Asian/Pacific Islander (A/PI): n = 1,002; and Black: n = 846). Median ages (years) differed significantly by race/ethnicity: White: 62.1, Hispanic: 57.3, A/PI: 60.7, and Black: 56.8 (P < 0.01 each race versus White). Overall survival (OS) was superior in Era‐2 versus Era‐1 for all patients (5‐year: 76.7% versus 67.4%, respectively, P < 0.001). Further, survival was significantly improved for all age groups P = 0.0019), and females (P < 0.001) across eras. Females had superior OS compared with males in Era‐1 (P = 0.004), but not in Era‐2. Additionally, all races, except A/PI, had improved 5‐year OS rates from Era‐1 to Era‐2. Finally, OS improved across eras for lower and higher SES populations; however those with higher SES were superior to lower SES patients in both eras. In conclusion, and in the largest comprehensive evaluation of US‐based FL patients to date, we show that despite improvements in OS for FL over time, critical disparities across races/ethnicities, sex, and age groups remain in the modern era and warrant further studies. Am. J. Hematol. 89:633–638, 2014.Keywords
This publication has 24 references indexed in Scilit:
- The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCLBlood, 2012
- Lymphoid Malignancies in U.S. Asians: Incidence Rate Differences by Birthplace and AcculturationCancer Epidemiology, Biomarkers & Prevention, 2011
- InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directionsBlood, 2010
- Follicular lymphomaAnnals of Oncology, 2010
- Measuring cancer survival in populations: relative survival vs cancer-specific survivalInternational Journal of Epidemiology, 2010
- Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology GroupJNCI: Journal of the National Cancer Institute, 2009
- Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based StudyJournal of Clinical Oncology, 2009
- Lymphoma survival patterns by WHO subtype in the United States, 1973–2003Cancer Causes & Control, 2008
- Association of Insurance with Cancer Care Utilization and OutcomesCA: A Cancer Journal for Clinicians, 2008
- Improved Survival of Follicular Lymphoma Patients in the United StatesJournal of Clinical Oncology, 2005